

GMP Interleukin Market Scope: Industry Analysis,
Market Size, Growth, Trends Till 2031
Request Sample Report
The GMP Interleukin market is experiencing robust growth, driven by increasing demand for biologics and advanced therapies. The market size is projected to reach approximately $1.2 billion by 2025. Key factors influencing this growth include rising research activities, advancements in manufacturing technologies, and collaborations among biotech firms and research institutions.
◍ Miltenyi Biotec
◍ Bio-Techne
◍ GE Healthcare
◍ Lonza
◍ CellGenix
◍ ReproCELL
◍ PeproTech
◍ Sino Biological
◍ Creative Bioarray
◍ Akron Biotech
◍ Almog
The GMP Interleukin Market is driven by companies like Miltenyi Biotec, Bio-Techne, GE Healthcare, and Lonza, which provide high-quality cytokines for research and therapeutic applications. Their innovations enhance production standards, expanding market access. Notable sales revenues include Bio-Techne ($1.03 billion) and Lonza ($5.73 billion) for overall operations.
Request Sample Report
Cell/Gene Therapy ◍ Tissue-Engineered Products
Others
Request Sample Report
25μg
50μg
Others
Request Sample Report
$ X Billion USD